• Immunosensor Could Improve Blood-Based Testing for Colorectal Cancer

    Apr 17 | Diagnostics World | Researchers at The University of Texas at El Paso (UTEP) are developing a point-of-care device for diagnosing colorectal cancer which, like blood glucose devices, uses electrochemical sensors. The microchip electrode features an immunosensor that detects disease biomarkers in a drop of blood, opening the possibility of an accessible, inexpensive test for the nation’s second leading cause of cancer-related deaths. More

  • ‘Funky Shape’ Gets Magnetic Robots Rolling in the Colon in Search of Cancer

    Apr 16 | Diagnostics World | Magnetic flexible endoscopes (MFEs) have up to now had a few disadvantages limiting their use inside the human body for performing virtual biopsies, notably navigation-related difficulties related to their traditional cylindrical shape. These robot-assisted devices use magnetic forces to propel and maneuver through lumens like the colon, but rotation happens in only two directions that limits the scope's ability to effectively perform procedures. More

  • Latest Biological Clock Ties ‘Bioenergetic Capacity’ to Alzheimer’s Risk

    Apr 15 | Diagnostics World | The “bioenergetic capacity” of individuals, as marked by the level of certain cognition-associated molecules in the blood, could potentially be predictive of the risk of developing Alzheimer’s and other age-related diseases. A simulated clinical trial suggests that turning back the wheels on that biological clock could be just as effective at slowing cognitive decline as the latest drug to be approved for that purpose by the U.S. Food and Drug Administration. More

  • Diagnostic Imaging Developments: Researchers Pursue New Tools, Technologies, and Techniques to Read X-Rays, Enhance Image Quality, and Improve Visualization

    Apr 10 | Diagnostics World | Researchers worldwide are looking to revamp traditional approaches to medical imaging and develop alternative solutions that could improve visualization, speed, and accuracy in diagnostic settings. At the University of Arkansas, for example, one group is developing an AI tool designed to help radiologists and doctors analyze chest X-rays and computed tomography (CT) scans, with an emphasis on understanding how the AI assistant arrives at its conclusions. More

  • Throat Swabs May Hold Clues to General Health of Older Individuals

    Apr 08 | Diagnostics World | The impact of the throat microbiome on the health of older individuals has gone unappreciated, especially among individuals being cared for in long-term care facilities. One big reason is that they are largely isolated and often forgotten by the public, even as these facilities have become home to a greater proportion of the overall population. More

  • Danger Ahead: How AI-Enabled Remote Cardiac Monitoring Technology Can Mitigate the Growing AFib Crisis

    Apr 04 | Diagnostics World | Atrial Fibrillation (AFib) is a fast-growing public health crisis—three times more common than once thought. Today, at least 10.55 million US adults have AFib, far exceeding the 3.3 million cases researchers predicted for the year 2020 in 1996. And this crisis is only growing. More

  • Babson Diagnostics’ BetterWay Blood Test Available at National Retailer

    Apr 03 | Diagnostics World | Last week, Babson Diagnostics entered an agreement with Sam’s Club to offer BetterWay blood testing. BetterWay is currently available in seven Sam’s Club pharmacies in the greater Austin area. The agreement with Sam’s Club marks a significant milestone for accessible blood testing for patients. More

  • Texas District Court Vacates FDA LDT Rule

    Apr 01 | Diagnostics World | The U.S. District Court for the Eastern District of Texas granted a motion for summary judgment yesterday, vacating the FDA rule that would have regulated LDTs as medical devices under the Federal Food, Drug and Cosmetic Act. More

  • PathAI’s Pathology Assessment Tool, Mayo Clinic Collaboration, More

    Mar 27 | Diagnostics World | PathAI received full qualification for AIM-MASH AI Assist1; Mayo Clinic Laboratories and Amprion announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States; and more. More

  • Follow the Money: Shingles Vaccine, Blood Stem Cell Therapies, More

    Mar 26 | Diagnostics World | Curevo will advance development of amezosvatein, the company’s vaccine for shingles; Garuda aims to address the growing need for off-the-shelf and cost-effective solution to stem cell transplants; and more. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more